RADL3 Stock Overview
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil.
Raia Drogasil Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||R$19.85|
|52 Week High||R$27.66|
|52 Week Low||R$17.83|
|1 Month Change||3.22%|
|3 Month Change||-16.17%|
|1 Year Change||-19.70%|
|3 Year Change||30.42%|
|5 Year Change||41.56%|
|Change since IPO||2,804.88%|
Recent News & Updates
There Are Reasons To Feel Uneasy About Raia Drogasil's (BVMF:RADL3) Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
With EPS Growth And More, Raia Drogasil (BVMF:RADL3) Is Interesting
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Does Raia Drogasil (BVMF:RADL3) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
|RADL3||BR Consumer Retailing||BR Market|
Return vs Industry: RADL3 exceeded the BR Consumer Retailing industry which returned -31.1% over the past year.
Return vs Market: RADL3 exceeded the BR Market which returned -31.2% over the past year.
|RADL3 Average Weekly Movement||4.4%|
|Consumer Retailing Industry Average Movement||5.4%|
|Market Average Movement||5.9%|
|10% most volatile stocks in BR Market||9.2%|
|10% least volatile stocks in BR Market||2.8%|
Stable Share Price: RADL3 is not significantly more volatile than the rest of BR stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: RADL3's weekly volatility (4%) has been stable over the past year.
About the Company
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of March 31, 2022, the company operated a network of 2,530 drug stores in 26 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo, Tocantins, and Pernambuco.
Raia Drogasil Fundamentals Summary
|RADL3 fundamental statistics|
Is RADL3 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|RADL3 income statement (TTM)|
|Cost of Revenue||R$17.58b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||0.44|
|Net Profit Margin||2.87%|
How did RADL3 perform over the long term?See historical performance and comparison
1.2%Current Dividend Yield
Is RADL3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 0/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for RADL3?
Other financial metrics that can be useful for relative valuation.
|What is RADL3's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does RADL3's PE Ratio compare to its peers?
|RADL3 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
Price-To-Earnings vs Peers: RADL3 is expensive based on its Price-To-Earnings Ratio (45.5x) compared to the peer average (14.5x).
Price to Earnings Ratio vs Industry
How does RADL3's PE Ratio compare vs other companies in the Consumer Retailing Industry?
Price-To-Earnings vs Industry: RADL3 is expensive based on its Price-To-Earnings Ratio (45.5x) compared to the BR Consumer Retailing industry average (13.8x)
Price to Earnings Ratio vs Fair Ratio
What is RADL3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||45.5x|
|Fair PE Ratio||24.4x|
Price-To-Earnings vs Fair Ratio: RADL3 is expensive based on its Price-To-Earnings Ratio (45.5x) compared to the estimated Fair Price-To-Earnings Ratio (24.4x).
Share Price vs Fair Value
What is the Fair Price of RADL3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: RADL3 (R$19.85) is trading above our estimate of fair value (R$17.63)
Significantly Below Fair Value: RADL3 is trading above our estimate of fair value.
Price to Earnings Growth Ratio
PEG Ratio: RADL3 is poor value based on its PEG Ratio (2.1x)
Discover undervalued companies
How is Raia Drogasil forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RADL3's forecast earnings growth (21.2% per year) is above the savings rate (9.1%).
Earnings vs Market: RADL3's earnings (21.2% per year) are forecast to grow faster than the BR market (7.1% per year).
High Growth Earnings: RADL3's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: RADL3's revenue (12.6% per year) is forecast to grow faster than the BR market (5.7% per year).
High Growth Revenue: RADL3's revenue (12.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RADL3's Return on Equity is forecast to be high in 3 years time (21.2%)
Discover growth companies
How has Raia Drogasil performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: RADL3 has high quality earnings.
Growing Profit Margin: RADL3's current net profit margins (2.9%) are higher than last year (2.6%).
Past Earnings Growth Analysis
Earnings Trend: RADL3's earnings have grown by 9% per year over the past 5 years.
Accelerating Growth: RADL3's earnings growth over the past year (34.2%) exceeds its 5-year average (9% per year).
Earnings vs Industry: RADL3 earnings growth over the past year (34.2%) exceeded the Consumer Retailing industry 3.5%.
Return on Equity
High ROE: RADL3's Return on Equity (15.3%) is considered low.
Discover strong past performing companies
How is Raia Drogasil's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: RADL3's short term assets (R$8.5B) exceed its short term liabilities (R$5.9B).
Long Term Liabilities: RADL3's short term assets (R$8.5B) exceed its long term liabilities (R$4.9B).
Debt to Equity History and Analysis
Debt Level: RADL3's net debt to equity ratio (35.5%) is considered satisfactory.
Reducing Debt: RADL3's debt to equity ratio has increased from 16.3% to 45.2% over the past 5 years.
Debt Coverage: RADL3's debt is well covered by operating cash flow (56.5%).
Interest Coverage: RADL3's interest payments on its debt are well covered by EBIT (3.7x coverage).
Discover healthy companies
What is Raia Drogasil current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: RADL3's dividend (1.21%) isn’t notable compared to the bottom 25% of dividend payers in the BR market (1.74%).
High Dividend: RADL3's dividend (1.21%) is low compared to the top 25% of dividend payers in the BR market (7.74%).
Stability and Growth of Payments
Stable Dividend: RADL3's dividend payments have been volatile in the past 10 years.
Growing Dividend: RADL3's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (125%), RADL3's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Marcílio Pousada (56 yo)
Mr. Marcílio D'Amigo Pousada has been the Chief Executive Officer of Raia Drogasil S.A. since July 1, 2013 and serves as its Member of Executive Board. Mr. Pousada serves as the Chief Executive Officer of...
Experienced Board: RADL3's board of directors are considered experienced (5.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Raia Drogasil S.A.'s employee growth, exchange listings and data sources
- Name: Raia Drogasil S.A.
- Ticker: RADL3
- Exchange: BOVESPA
- Founded: 1905
- Industry: Drug Retail
- Sector: Consumer Retailing
- Implied Market Cap: R$32.708b
- Shares outstanding: 1.65b
- Website: https://www.rd.com.br
Number of Employees
- Raia Drogasil S.A.
- Av. Corifeu de Azevedo Marques, 3097
- São Paulo
- São Paulo
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/24 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.